Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Sylvie van der Werf and Pauline Maisonnasse.
Sylvie van der Werf
Connection Strength
0.457
Pauline Maisonnasse
  1. Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates. Nature. 2020 09; 585(7826):584-587.
    View in: PubMed
    Score: 0.223
  2. An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates. Cell Host Microbe. 2021 09 08; 29(9):1437-1453.e8.
    View in: PubMed
    Score: 0.060
  3. SARS-CoV-2 viral dynamics in non-human primates. PLoS Comput Biol. 2021 03; 17(3):e1008785.
    View in: PubMed
    Score: 0.058
  4. Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection. Cell. 2021 03 04; 184(5):1188-1200.e19.
    View in: PubMed
    Score: 0.058
  5. SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota. Gut Microbes. 2021 Jan-Dec; 13(1):1-19.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.